Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Head-to-Head: which drug combo works best for psoriatic arthritis?

NCT ID NCT07398651

First seen Feb 16, 2026 · Last updated May 08, 2026 · Updated 14 times

Summary

This study compares two treatments for psoriatic arthritis: apremilast plus methotrexate versus adalimumab plus methotrexate. It will include 60 adults who did not get enough relief from methotrexate alone. The goal is to see which combination better controls joint and skin symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tanta University

    Tanta, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.